Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Stomatologiia (Mosk) ; 70(1): 17-9, 1991.
Article in Russian | MEDLINE | ID: mdl-1711722

ABSTRACT

Infected mandibular fracture was simulated in rats. 10 percent calcium chloride solution (control) or andecalin (10 U/Kg) and contrykal (2.5000 U/kg) were administered to fracture site by vacuum electrophoresis. Histologic examination has revealed that andecalin activated the exudative phase of inflammation and decelerated the proliferative processes. A contrary effect was induced by contrykal: rapidly decreasing exudation, activation of osteoclastic resorption of necrotic bone and of osteogenesis processes.


Subject(s)
Aprotinin/therapeutic use , Mandibular Fractures/drug therapy , Pancreatic Extracts/therapeutic use , Peptide Hydrolases/therapeutic use , Povidone/therapeutic use , Wound Infection/drug therapy , Animals , Bone Regeneration/drug effects , Drug Combinations , Drug Evaluation, Preclinical , Mandibular Fractures/complications , Mandibular Fractures/pathology , Rats , Rats, Inbred Strains , Time Factors , Wound Healing/drug effects , Wound Infection/etiology , Wound Infection/pathology
2.
Stomatologiia (Mosk) ; 69(3): 9-11, 1990.
Article in Russian | MEDLINE | ID: mdl-2202091

ABSTRACT

Soluble and total protein content and cathepsin D activity were measured in rat mandibular bone tissue during healing of a fracture treated with proteolytic enzymes (andecalin) or protease inhibitors (contrykal) electrophoresis. Contrykal essentially elevated collagen content in mandibular bone tissue and reduced lysosomal enzymes activity. Andecalin had no noticeable effect on the levels of total protein and collagen, but it significantly increased the activity of cathepsin D. The findings evidence that local contrykal electrophoresis in the focus of injury creates an effective concentration of the drug that enhances the fracture healing and prevents the development of pyoinflammatory complications.


Subject(s)
Bone and Bones/metabolism , Cathepsin D/metabolism , Mandible/metabolism , Mandibular Fractures/metabolism , Proteins/metabolism , Animals , Bone and Bones/drug effects , Drug Evaluation, Preclinical , Female , Male , Mandible/drug effects , Mandibular Fractures/drug therapy , Peptide Hydrolases/therapeutic use , Protease Inhibitors/therapeutic use , Proteins/drug effects , Rats , Rats, Inbred Strains , Solubility , Wound Healing/drug effects , Wound Healing/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...